Nollahealth

Nolla Health, operating as the legal entity Magic Health, Inc. d/b/a Nolla Health, is a technology company offering AI-assisted, clinician-reviewed care delivered directly to consumers through mobile apps and its website. Its core flow, marketed as Nolla MD, has users walk through their symptoms in a guided chat and optionally submit images for analysis, after which a licensed U.S. clinician reviews the case and responds by message, issuing a care plan and, where appropriate, prescriptions sent to the user's pharmacy. The company states that every diagnosis and prescription is reviewed and approved by a licensed U.S. medical provider and that clinician review can be returned in as little as ten minutes.

The company's first specialty product is skin care: the Nolla Skin / Nolla Acne app provides AI-powered skin scans that track changes over time, asynchronously prescribed clinician-reviewed treatment plans, and custom compounded medications manufactured in the U.S. and shipped to patients. A birth control offering is described as in development. Nolla positions itself as building the full stack — diagnosis, tracking, prescribing and referral — around its own AI models rather than layering language models onto existing systems.

Nolla Health is not itself a medical practice; it provides administrative, management and technology services and connects users to independent, physician-owned medical practices, including SteadyMD and its affiliated physician groups in states such as Missouri, California, New Jersey, Florida, Michigan and Colorado, which employ or contract the clinicians who deliver care.

Founding story

Co-founder and CEO Luis Wenus has described growing up with a doctor in the family and later recognizing that continuous, personalized access to a clinician who knows a patient's history is rare, motivating the company's aim to make that experience broadly available using current technology.

Business model

Direct-to-consumer telehealth technology platform. Nolla operates the software and administrative layer and contracts with independent physician-owned medical practices that supply licensed clinicians; users pay Nolla for access to guided assessment, clinician review, treatment plans and dispensed medications.

Consumer payments processed through Stripe: a $39 per-case clinician message review on the Nolla MD flow, and a $59 per month subscription for the Acne Care app, which includes clinician-reviewed treatment and custom compounded medications shipped to the patient.

Traction

Prior to U.S. entry, Nolla treated more than 50,000 patients in Norway within six months, and its acne and skin cancer screening apps ranked among the top five medical apps in the App Store there. The U.S. service went live in more than 40 states in September 2025.

Latest developments

In September 2025 the company announced a $4.5 million seed round led by General Catalyst with SNÖ Ventures and Commure founder Diede van Lamoen participating, opened its New York City headquarters, and launched its Acne Treatment App across 40+ U.S. states. Capital is directed at U.S. operations, clinical and engineering hiring, and R&D on additional condition-specific apps.